Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 1,153 | 1,226 | 21,560 | 28,189 | 42,131 |
Short-term investment |
| 13,983 | 9,714 | 0 | 0 | 0 |
Accounts receivables |
| 11,634 | 14,134 | 16,765 | 24,239 | 17,925 |
Inventories |
| 17,723 | 18,639 | 21,452 | 28,286 | 30,004 |
Deferred income taxes |
| 0 | 791 | 343 | 577 | 979 |
Other current assets |
| 2,007 | 2,296 | 1,627 | 2,224 | 2,078 |
Total current assets |
| 46,501 | 46,798 | 61,747 | 83,515 | 93,117 |
Gross property plant... |
| 20,837 | 27,732 | 36,947 | 43,141 | 47,142 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 20,837 | 27,732 | 36,947 | 43,141 | 47,142 |
Work in Progress |
| 4,919 | 9,197 | 7,106 | 4,699 | 2,119 |
Miscellaneous Investment |
| 5,813 | 353 | 553 | 1,298 | 1,281 |
Deferred income taxes |
| 216 | 44 | 718 | 436 | 434 |
Intangible assets |
| 41 | 36 | 50 | 75 | 53 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 2,056 | 1,197 | 620 | 583 | 242 |
Total non-current assets |
| 33,882 | 38,559 | 45,994 | 50,232 | 51,270 |
Total assets |
| 80,383 | 85,357 | 107,741 | 133,747 | 144,388 |
Short-term debt |
| 1,056 | 336 | 4 | 0 | 0 |
Accounts Payable... |
| 4,923 | 5,907 | 7,632 | 7,957 | 7,625 |
Provisions |
| 11 | 25 | 25 | 42 | 49 |
Taxes Payable |
| 42 | 99 | 60 | 17 | 22 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 8 | 8 | 8 | 5 |
Other current liabilities |
| 2,436 | 2,893 | 3,396 | 3,932 | 3,310 |
Total current liabilities |
| 8,468 | 9,268 | 11,125 | 11,956 | 11,011 |
Long-term debt |
| 0 | 0 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 2,212 | 2,740 | 3,381 | 4,214 | 5,372 |
Provisions |
| 132 | 205 | 253 | 267 | 306 |
Capital Leases |
| 0 | 45 | 37 | 29 | 28 |
Other longterm liabilities |
| 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities |
| 2,344 | 2,990 | 3,670 | 4,510 | 5,706 |
Total liabilities |
| 10,811 | 12,258 | 14,795 | 16,465 | 16,717 |
Share Capital |
| 531 | 531 | 531 | 531 | 531 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 69,041 | 72,568 | 92,415 | 116,751 | 127,140 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 69,572 | 73,099 | 92,946 | 117,282 | 127,671 |
Total Liabilities and Equity |
| 80,383 | 85,357 | 107,741 | 133,747 | 144,388 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |